Infectious Diseases

< Back

Overview

The groups of this area aim to improve the outcomes of patients with infectious diseases. The Epidemiology and Public Health group focuses on the epidemiology and prevention of healthcare acquired infections, transmissible infections and on the new vaccines. The Infectious Diseases group focuses on improving the strategies of clinical problems observed in clinical practice. The Microbiology group studies the mechanisms of antimicrobial resistance, pathogenicity, genomic epidemiology and infectious diseases diagnostics. The CRIPS group focuses on developing translational and clinical research in critical care, while the SODIR group works in the areas of sepsis, organ dysfunction and resuscitation. There is also a group focused on clinical research on children’s infectious diseases and primary immunodeficiencies. Finally, the CIBBIM-Nanomedicine group Works in the synthesis, characterization and applications of engineered inorganic nanoparticles in the field of infectious diseases.

Publications

260
total
1322
impact factor
5.08
average impact factor

Group Leader: Benito Almirante Gragera

During 2019, the Research Group on Infectious Diseases has developed projects related to new therapeutic options for multi-resistant bacterial infections, like electric stimulation to eradicate microorganisms in the biofilms of prosthetic devices, the epidemiology and therapy of tropical diseases in our country, with the epidemiology and prognosis of serious infections in immunocompromised patients and assessment of new strategies for antiretroviral treatment. Our group has published 121 articles in indexed biomedical journals and has obtained 6 projects with competitive funding (about 800.000€ of amount awarded). Researchers of our group have been directors of 5 Doctoral Theses during the year 2019. Our group has established research synergies with various national and international groups, through their participation in 3 Cooperative Research Networks from the Health Institute Carlos III (REIPI, RIS and RICET), collaboration agreements with organizations and international research groups in the field of international health. During 2019 our group has consolidated the new line of research in the field of basic and translational research related to HIV eradication of patients infected with this virus.

VHIR Annual Report 2019